• Design & Use
  • Key Facts
  • Development
  • Composition
  • Pharmacology
  • Dosing schedule
  • Ring insertion and removal
  • Vaginal administration
  • Everyday questions about NuvaRing
• Pharmacology
  • Key Facts
  • Pharmacokinetics
  • Pharmacodynamics
• Efficacy
  • Key Facts
  • User compliance
  • Efficacy
• Cycle Control
  • Key Facts
  • Cycle control with NuvaRing
  • Withdrawal bleeding
  • Irregular bleeding
  • Intended bleeding pattern
  • Bleeding-related discontinuation
• Acceptability
  • Key Facts
  • Tolerability
  • User acceptability
• Safety
  • Key Facts
  • Cardiovascular risk
  • Local effects
  • Gynecological cancer
  • Effects on other systems
• Resources
  • Newsletters
  • References
  • Poster library
  • Slide-set library
  • Video Nuvaring
• Your Patient
  • What is NuvaRing?
  • Is NuvaRing right for me?
  • Getting started with NuvaRing
  • Supporting services
  • FAQs
  • Resources

| Site Map Design & Use Key Facts Development Alternatives to COCs Contraceptive vaginal rings Composition Pharmacology Dosing schedule Ring insertion and removal Vaginal administration The Vagina Vaginal administration and its advantages Contraceptive vaginal rings Summary Everyday questions about NuvaRing Pharmacology Key Facts Pharmacokinetics Ethinylestradiol Serum concentration Absolute bioavailability Metabolism and elimination Etonogestrel Serum concentration Absolute bioavailability Metabolism and elimination Drug Interactions Vaginal drug interactions Other drug interactions Summary Pharmacodynamics Ovarian suppression Return to ovulation after ring removal Deviations from recommended regimen Endometrial effects Efficacy Key Facts User compliance Efficacy Cycle Control Key Facts Cycle control with NuvaRing Withdrawal bleeding Irregular bleeding Intended bleeding pattern Bleeding-related discontinuation Acceptability Key Facts Tolerability Adverse events Effect on body weight User acceptability Safety Key Facts Cardiovascular risk Lipid metabolism Carbohydrate metabolism Blood pressure Hemostatic variables Conclusions Local effects Gynecological cancer Effects on other systems Resources Newsletters References Poster library Slide-set library Video Nuvaring Your Patient What is NuvaRing? Why choose NuvaRing? How NuvaRing works Why vaginal administration? Using NuvaRing Is NuvaRing right for me? Compare methods Review all methods Full prescribing information Getting started with NuvaRing Talking to your Healthcare Provider Starting NuvaRing Availability of NuvaRing Supporting services Testimonials FAQs Introducing NuvaRing Reliability and Dosage Starting NuvaRing Removing NuvaRing Your periods Side effects and safety Where is NuvaRing Available? Resources Contraception through the ages Links Interact with NuvaRing

Site map | About this site | Privacy statement | Terms of use | Prescribing information | About us

© 2008 Schering-Plough Corporation. All rights reserved.

This site is intended for healthcare professionals outside the USA.